The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression
Abstract
Prostate cancer (PCa) cells express vitamin D receptors (VDR) and 1,25‐dihydroxyvitamin D 3 (1,25(OH)2 D 3) inhibits the growth of epithelial cells derived from normal, benign prostate hyperplasia, and PCa as well as established PCa cell lines. The growth inhibitory effects of 1,25(OH)2 D 3 in cell cultures are modulated tissue by the presence and activities of the enzymes 25‐hydroxyvitamin D 3 24‐hydroxylase which initiates the inactivation of 1,25(OH)2 D 3 and 25‐hydroxyvitamin D 3 1α‐hydroxylase which catalyses its synthesis. In LNCaP human PCa cells 1,25(OH)2 D 3 exerts antiproliferative activity predominantly by cell cycle arrest through the induction of IGF binding protein‐3 (IGFBP‐3) expression which in turn increases the levels of the cell cycle inhibitor p21 leading to growth arrest. cDNA microarray analyses of primary prostatic epithelial and PCa cells reveal that 1,25(OH)2 D 3 regulates many target genes expanding the possible mechanisms of its anticancer activity and raising new potential therapeutic targets. Some of these target genes are involved in growth regulation, protection from oxidative stress, and cell–cell and cell–matrix interactions. A small clinical trial has shown that 1,25(OH)2 D 3 can slow the rate of prostate specific antigen (PSA) rise in PCa patients demonstrating proof of concept that 1,25(OH)2 D 3 exhibits therapeutic activity in men with PCa. Further investigation of the role of calcitriol and its analogs for the therapy or chemoprevention of PCa is currently being pursued. J. Cell. Biochem. 88: 363–371, 2003. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326
Self-citationThe Current State of Hormonal Therapy for Prostate Cancer
Hellerstedt, B. A., & Pienta, K. J. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.3.154 · Cited by 386
Cited by
Noncalcemic Actions of Vitamin D Receptor Ligands
Nagpal, S., Na, S., & Rathnachalam, R. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0002 · Cited by 961
Mosekilde, L. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02226.x · Cited by 417
The pleiotropic actions of vitamin D
Lin, R., & White, J. H. (2004) · BioEssays · doi:10.1002/bies.10368 · Cited by 267
Metadata
- Authors
- Krishnan, A. V., Peehl, D. M., & Feldman, D.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2003-01-06
- Volume
- 88
- Issue
- 2
- Pages
- 363-371
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W1998843836
- Cited by
- 184
- References
- 2
- FWCI
- 14.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.